Ophthalmic diseases specialist Oculis Holding AG announced positive phase II data showing its serum-glucose corticoid ...

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

An estimated 24 million Americans will use these weight loss drugs by 2035, posing significant challenges as well as ...

Losing weight by dieting (restricting energy) includes, along with fat loss, losing lean mass, about half of which is ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

President-elect Donald Trump has chosen two prominent men to lead health-related affairs in his administration, Mehmet Oz, MD, and Robert Kennedy, Jr. While the two leaders will be leading health ...

Sugar substitutes, substance abuse, GLP-1 drugs, and the biggest clinical trials of the year—each had their place in our top 10.

Mount Sinai researchers discovered that harmine, a beta cell regenerative drug, may transform alpha cells into beta cells, ...

Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

The quest for effective weight loss solutions has never been more urgent, with millions of people worldwide struggling to ...

The world’s richest man has clashed with incoming Health and Human Services chief Robert F. Kennedy Jr. over the role ...

Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...